Thenalidine
Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug.[1] It was withdrawn from the US, Canadian, and UK markets in 1963 due to a risk of neutropenia.[2]
![]() | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.001.501 |
| Chemical and physical data | |
| Formula | C17H22N2S |
| Molar mass | 286.44 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| | |
References
- Getzler NA, Ereaux LP (March 1959). "Evaluation of thenalidine tratrate (sandostene) in dermatological disorders". Canadian Medical Association Journal. 80 (6): 445–8. PMC 1830689. PMID 13629433.
- "Thenalidine". DrugBank.
Antipruritics (D04) | |
|---|---|
| Antihistamines for topical use |
|
| Anesthetics for topical use |
|
| Others | |
Antihistamines (R06) | |
|---|---|
| Benzimidazoles (*) |
|
| Diarylmethanes |
|
| Ethylenediamines |
|
| Tricyclics |
|
| Others |
|
| For topical use |
|
Acetylcholine receptor modulators | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||
Histamine receptor modulators | |
|---|---|
| H1 |
|
| H2 |
|
| H3 |
|
| H4 | |
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
